2023
DOI: 10.1002/exp.20210043
|View full text |Cite
|
Sign up to set email alerts
|

Bioinspired gradient scaffolds for osteochondral tissue engineering

Yachen Peng,
Yaling Zhuang,
Yang Liu
et al.

Abstract: Repairing articular osteochondral defects present considerable challenges in self‐repair due to the complex tissue structure and low proliferation of chondrocytes. Conventional clinical therapies have not shown significant efficacy, including microfracture, autologous/allograft osteochondral transplantation, and cell‐based techniques. Therefore, tissue engineering has been widely explored in repairing osteochondral defects by leveraging the natural regenerative potential of biomaterials to control cell functio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
19
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(19 citation statements)
references
References 130 publications
0
19
0
Order By: Relevance
“…In recent years, the burgeoning advancements in materials science have heralded transformative changes in the treatment of bone-related diseases. Novel materials, including electrospun fibers integrated with bioactive molecules, iron-based metal–organic frameworks embedded in PLGA nanofiber scaffolds, dynamic adaptive scaffolds with bionic gradient scaffolds, and biofunctionalized composite scaffolds, have emerged as agents capable of enhancing osteogenic differentiation, promoting vascularized bone regeneration, and addressing bone defects. Therefore, we believe that the most advantageous therapeutic strategy for addressing aseptic loosening is to develop a pharmacological agent characterized by a sustained release in the periprosthetic bone microenvironment. This pharmaceutical entity should exhibit proficiency in impeding osteoclast activity, promoting osteogenesis, and mitigating the adverse consequences of wear particles on bone microstructure and strength.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, the burgeoning advancements in materials science have heralded transformative changes in the treatment of bone-related diseases. Novel materials, including electrospun fibers integrated with bioactive molecules, iron-based metal–organic frameworks embedded in PLGA nanofiber scaffolds, dynamic adaptive scaffolds with bionic gradient scaffolds, and biofunctionalized composite scaffolds, have emerged as agents capable of enhancing osteogenic differentiation, promoting vascularized bone regeneration, and addressing bone defects. Therefore, we believe that the most advantageous therapeutic strategy for addressing aseptic loosening is to develop a pharmacological agent characterized by a sustained release in the periprosthetic bone microenvironment. This pharmaceutical entity should exhibit proficiency in impeding osteoclast activity, promoting osteogenesis, and mitigating the adverse consequences of wear particles on bone microstructure and strength.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, tissue engineering scaffolds with photothermal effect can promote the regeneration of bone defects after osteosarcoma surgery. First of all, for bone defect regeneration, bone tissue engineering (BTE) has brought new hope . Many materials used for bone repair such as metals, ceramics, and polymers can be prepared by tissue engineering techniques like three-dimensional (3D) printing into multiscale bionic structural bioscaffolds that facilitate cellular tissue adhesion. The 3D structure of the stent not only provides an environment for cell adhesion and growth but also functions as a controlled release for drugs and other molecules, which provides conditions for photothermal treatment of osteosarcoma.…”
Section: Introductionmentioning
confidence: 99%
“…Considering this, nanocomposite materials present a promising avenue to address these challenges, combining the favorable properties of nanoparticles and organic matrices. 33–35 However, achieving good compatibility between inorganic components and organic matrices remains a substantial technical hurdle.…”
Section: Introductionmentioning
confidence: 99%